Lena Gowring, DO
Dermatology · Keesler Afb, MSNPI 1639343312
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 223 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 29.8% of the total. That places this record below the midpoint for dermatology clinicians in MS, where the typical reported total is $4,621.
Across 223 payments — averaging $23.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$588
- Regeneron$526
- Johnson & Johnson$307
- Sun Pharmaceutical Industries Inc.$280
- Lilly USA, LLC$253
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,95096%
- Education$2274%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 82 | $1,544 |
| Novartis | 36 | $588 |
| Regeneron | 2 | $526 |
| Johnson & Johnson | 10 | $307 |
| Sun Pharmaceutical Industries Inc. | 8 | $280 |
| Lilly USA, LLC | 9 | $253 |
| UCB, Inc. | 13 | $241 |
| LEO Pharma Inc. | 10 | $212 |
| Galderma Laboratories, L.p. | 5 | $188 |
| Regeneron Healthcare Solutions, Inc. | 7 | $187 |
| Sanofi | 9 | $169 |
| Revance Therapeutics, Inc. | 1 | $125 |
| Incyte Corporation | 5 | $87 |
| E.r. Squibb & Sons, L.L.C. | 5 | $79 |
| Pfizer | 5 | $75 |
| Organogenesis Inc. | 3 | $73 |
| Genentech USA, Inc. | 3 | $56 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
| Boehringer Ingelheim | 2 | $48 |
| Amgen | 2 | $27 |
| VYNE Pharmaceuticals Inc. | 1 | $24 |
| Dermavant Sciences, Inc. | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,177 in reported general payments places this provider in the 50th percentile of 78 dermatology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 12 | $163,481 |
| Clobetasol Propionate | 105 | $3,070 |
| Fluorouracil | 31 | $2,932 |
| Glycopyrrolate | 14 | $1,695 |
| Doxycycline Hyclate | 22 | $1,240 |
| Ketoconazole | 75 | $769 |
| Dutasteride | 91 | $722 |
| ValacyclovirValacyclovir Hcl | 41 | $566 |
| Fluocinolone Acetonide Oil | 13 | $433 |
| Triamcinolone Acetonide | 47 | $415 |
| Ciclopirox | 13 | $235 |
| Dexamethasone | 26 | $226 |
| Minoxidil | 19 | $83 |
| Amitriptyline Hcl | 18 | $68 |
| Montelukast Sodium | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Keesler Afb
- Jeremy JacksonJackson$450K
- Lindsey ZubritskyOcean Springs$349K
- Maureen OffiahHattiesburg$275K
- Lyndsay ShippOxford$246K
- Steven ShapiroHattiesburg$165K
- Joseph TerracinaGreenville$86K
- Thy HuynhJackson$51K
- Patrick BolerClinton$44K
- Jeffrey HouinTupelo$27K
- Robert BrodellJackson$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.